EUCTR2009-016592-29-GB进行中（未招募）不适用
Reversibility of Acute ß-Blocker Induced Bronchoconstriction - SHO001
niversity of Dundee0 个研究点目标入组 14 人开始时间: 2010年3月17日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Informed consent and ability to perform spirometry, IOS, bronchial challenge and all domiciliary measurements. Mild to Moderate Asthmatics taking =1000µg BDP per day or equivalent. FEV1 >80% predicted with diurnal FEV1 variation <20% post wash out.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Uncontrolled symptoms of asthma. Exacerbation in past 6 months. Resting BP<110 systolic or HR<60. Pregnancy or lactation. Known or suspected sensitivity to IMP. Inability to comply with protocol. Any degree of heart block. Rate limiting medication including ß blockers, rate limiting Calcium Channel Blockers, and Amiodarone.
研究者
相似试验
招募中
不适用
Bronchodilator Reversibility and Clinical Outcomes in COPD PatientsCOPDTCTR20210322006Faculty of Medicine, Thammasat University150
已完成
不适用
The effect of prophylactic bronchodilator treatment with transdermal tulobuterol patch on lung compliance and airway resistanceDiseases of th respiratory systemKCT0001152Pusan National University Hospital82
已完成
不适用
Evaluation of bronchodilation induced by beta-adrenergic agents in COPD patients. -Three-dimensional CT Image analysisJPRN-UMIN000002668Hokkaido University Graduate School of Medicine, Department of Internal Medicine, Division of Respiratory Medicine20
已完成
不适用
Assessment of bronchodilation induced by beta-adrenergic agent and anti-cholinergic agent in COPD patients, using 3D CT Image analysisJPRN-UMIN000012043Division of Respiratory Medicine, Hokkaido University Graduate School of Medicine30
已完成
3 期
A study comparing the changes in lung function following the use of salbutamol and symbicort in adults with asthmaAsthmaACTRN12619001083189Medical Research Institute of New Zealand39